Banner
Pilot Study: Fibromyalgia Fatigue Improved By TENS Therapy

Fibromyalgia is the term for a poorly-understood condition where people experience pain and fatigue...

High Meat Consumption Linked To Lower Dementia Risk

Older people who eat large amounts of meat have a lower risk of dementia and cognitive decline...

Long Before The Inca Colonized Peru, Natives Had A Thriving Trade Network

A new DNA analysis reveals that long before the Incan Empire took over Peru, animals were...

Mesolithic People Had Meals With More Tradition Than You Thought

The common imagery of prehistoric people is either rooting through dirt for grubs and picking berries...

User picture.
News StaffRSS Feed of this column.

News Releases From All Over The World, Right To You... Read More »

Blogroll

Scientists know that information travels between brain cells along hairlike extensions called axons. For the first time, researchers have found that axons don’t just transmit information – they can turn the signal up or down with the right stimulation.

This finding may help scientists develop treatments for psychiatric disorders such as depression and schizophrenia in which it is thought that different parts of the brain do not communicate correctly with each other.

The Regea Institute for Regenerative Medicine, which operates under the University of Tampere in Finland, administered the first clinical stem cell therapy to two patients in cooperation with the Tampere University Hospital. The therapy was a success.

The patients suffered from severe, prolonged frontal sinusitis. An implant combining stem cells and biomaterial was inserted into the damaged bone. Since the therapy, the patients have been well and no longer suffer from frontal sinusitis.

Stem cell therapy was administered to patients with prolonged and severely symptomatic frontal sinusitis that destroyed bone tissue in the forehead. Other treatments such as traditional implants or fat tissue transplants failed to relieve infection.

The Internet is serving as a fertile medium for "HIV denialists" to spread false ideas about HIV/AIDS, which could have terrible public health consequences, say scientists in a policy paper in PLoS Medicine.

"It may seem remarkable that, 23 years after the identification of HIV, there is still denial that the virus is the cause of AIDS," say Tara Smith (University of Iowa College of Public Health) and Steven Novella (Yale University School of Medicine). But with the arrival of the Internet, HIV denialist organizations such as "Reappraising AIDS" have reignited their campaign to spread misinformation.

A team has examined over 300,000 genetic markers in thousands of asthmatic children and compared their data with those of healthy controls. The newly found gene, ORMDL3, is a promising object of research: it could help to improve the prevention and diagnosis of asthma, and possibly to develop a new therapy.

The scientists used the fact that the genetic material of different individuals shows differences. One type of DNA variants is called SNPs, short for “Single Nucleotide Polymorphisms”. They can be compared and statistically analysed.

By creating "Teflon" versions of natural antibiotics found in frog skin, a research team led by biological chemist E. Neil Marsh has made the potential drugs better at thwarting bacterial defenses, an improvement that could enhance their effectiveness.

Marsh and collaborators work with compounds called antimicrobial peptides (AMPs), which are produced by virtually all animals, from insects to frogs to humans. AMPs are the immune system's early line of defense, battling microbes at the first places they try to penetrate: skin, mucous membranes and other surfaces. They're copiously produced in injured or infected frog skin, for instance, and the linings of the human respiratory and gastrointestinal tracts also crank out the short proteins in response to invading pathogens.

Non-medicinal interventions are highly effective in preventing the behavioral and academic problems associated with Attention Deficit Hyperactivity Disorder (ADHD), according to a five-year study led by researchers at Lehigh University’s College of Education.

The study, titled “Project Achieve” and funded by the National Institute of Mental Health (NIMH), was the largest of its kind focusing on children aged 3 to 5 who have shown significant symptoms of ADHD. It also involved researchers from Lehigh Valley Hospital in Allentown, Pa.

The researchers, led by George DuPaul, professor of school psychology at Lehigh; Lee Kern, professor of special education at Lehigh; and Dr.